Oncovin Injection (Vincristine Sulfate): Essential Vinca Alkaloid for Precision Hematology & Oncology – Global Supply by Ernest Oncology
In the sophisticated landscape of 2026 oncology, Oncovin Injection (containing the active ingredient Vincristine Sulfate) remains a fundamental component of curative-intent chemotherapy. Derived from the Madagascar periwinkle plant (Catharanthus roseus), Vincristine is a potent antineoplastic agent globally recognized for its efficacy in treating acute leukemias, lymphomas, and various childhood solid tumors.
Ernest Oncology, the specialized oncology division of Ernest Pharmaceutical Pvt. Ltd., is a premier Exporter, Bulk Supplier, and Distributor from India. We facilitate the secure, WHO-GMP-compliant international distribution of Oncovin Injection to the UK (London), USA, Abu Dhabi (UAE), Australia, and South Africa via validated pharmaceutical cold-chain logistics.
What is Oncovin Injection? (Mechanism & Clinical Indications)
Oncovin is a sterile, preservative-free solution for intravenous administration, typically available in strengths of 1 mg/1 mL and 2 mg/2 mL Vials. It is a cell-cycle-specific agent that arrests cell division during metaphase.
Primary Therapeutic Indications
Acute Lymphoblastic Leukemia (ALL): A core component of induction and maintenance regimens for both pediatric and adult ALL.
Hodgkin’s & Non-Hodgkin’s Lymphomas: Frequently utilized in multi-agent protocols such as CHOP and MOPP.
Wilms' Tumor & Neuroblastoma: A first-line treatment for these critical pediatric solid tumors.
Rhabdomyosarcoma: Integrated into the standard of care for soft tissue sarcomas.
Idiopathic Thrombocytopenic Purpura (ITP): Utilized in refractory cases to manage low platelet counts.
| Feature | Technical Specification |
| Brand Name | Oncovin |
| Active Ingredient | Vincristine Sulfate |
| Pharmacological Class | Vinca Alkaloid / Microtubule Disruptor |
| Available Strengths | 1 mg / 1 mL, 2 mg / 2 mL |
| Manufacturer | Leading GMP Indian Partners |
| Dosage Form | Solution for Injection |
| Storage | 2°C to 8°C (36°F to 46°F); Refrigeration Required |
Mechanism of Action: Inhibition of Microtubule Formation
Oncovin exerts its cytotoxic effects by targeting the structural framework of the cell:
Tubulin Binding: Vincristine binds to tubulin dimers, the building blocks of microtubules.
Polymerization Inhibition: It prevents the assembly of these dimers into functional microtubules, which are necessary for the formation of the mitotic spindle.
Metaphase Arrest: Without a functional spindle, chromosomes cannot align or separate, leading to cell cycle arrest in metaphase and subsequent apoptosis.
Marrow Sparing: Unlike many other cytotoxic agents, Oncovin has a relatively low impact on bone marrow, allowing it to be combined with more myelosuppressive drugs.
Clinical Administration & Safety
Neurotoxicity: The primary dose-limiting side effect is peripheral neuropathy, often manifesting as numbness, tingling, or motor weakness.
Vesicant Nature: Oncovin is a potent vesicant. If extravasation occurs, it can cause severe tissue irritation and necrosis.
Constipation: Autonomic neuropathy can lead to severe constipation or paralytic ileus; prophylactic stool softeners are often recommended.
Global Supply Chain: London, USA, UAE, Australia, & South Africa
Ernest Oncology ensures that international healthcare providers have uninterrupted access to high-quality Oncovin. We maintain a robust cold-chain logistical framework to ensure the biological integrity of every vial from India to your destination.
United Kingdom & London: Direct supply to NHS Trusts and private oncology centers in London, ensuring MHRA-compliant handling and rapid delivery.
United States: Bulk supply for hospital systems and specialty pharmacies seeking verified exports via Indian distribution channels.
Abu Dhabi & UAE: Fast-track shipping to the Middle East's premier "Medical Cities" and government health authorities.
Australia & South Africa: Strategic distribution to regional wholesalers, maintaining stable stock for national hematology programs.
📞 Contact Ernest Oncology — Pharmaceutical Exporter from India
(Group of Ernest Pharmaceutical Pvt. Ltd.)
Partner with a verified leader for the bulk procurement of essential oncology injectables.
🌐 Websites:
📧 Email:
📦 Business Type: Exporter | Bulk Supplier | Distributor
📲 WhatsApp: +91 93599 02383
🔗 Instant Chat:
